ISB and ETH Zurich Create Map of the Human Proteome
September 19, 2010
SEATTLE--The Institute for Systems Biology (ISB) in Seattle, Washington, and the Swiss Federal Institute of Technology (ETH Zurich) in Zurich, Switzerland announced today at the 9th Annual World Conference of the Human Proteome Organization (HUPO) in Sydney, Australia, that they have completed the first phase of generating a complete map of the human proteome by [...]
September 19, 2010
SYDNEY - At the Human Proteome Organisation's (HUPO) 9th Annual World Congress (https://www.hupo2010.com), Bruker displays leading technologies and solutions for proteomics in the next decade. Bruker's "Continuing Revolution" campaign demonstrates the company's commitment to enabling the proteomics community to pursue an ever increasing range of scientific investigations, as well as clinical proteomics research and emerging [...]
September 17, 2010
Shrink Nanotechnologies announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products. Within the last week, Shrink has received the final mold for the initial StemDisc product line. The balance of the design parameters have been completed, [...]
JPK Instruments Announce the Vortis(TM) Advanced Fully Digital SPM Control Station
September 17, 2010
Berlin - JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation in life sciences and soft matter announces the Vortis(TM) Advanced, the new standard in SPM Control systems with the lowest noise and highest signal speeds seen to date. Providing the highest performance of electronics controller for scanning probe microscopes, SPM, is one of the driving [...]
Coherent Ships 1000 Chameleon Lasers for MPE Imaging
September 17, 2010
Santa Clara, Calif. – Coherent Inc. (Santa Clara, CA) (Nasdaq: COHR) has now shipped 1000 of the company’s Chameleon lasers for use in multiphoton excitation (MPE) microscopy, making this broadly tunable “one-box” laser the market leader in this key bioimaging application. Chameleon lasers provide biologists with widely tunable, push button femtosecond output with pulse characteristics [...]
New Artificial Cerebrospinal Fluid (CSF)
September 17, 2010
Artificial Cerebrospinal Fluid (CSF) closely matches the electrolyte concentrations and osmolality found in authentic cerebrospinal fluid. Artificial CSF is commonly used as a sterile diluent or flushing fluid for delivery of molecules into the brain. It can also be used when sampling brain interstitial fluid. Artificial CSF manufactured by Harvard Apparatus is perfect for use [...]
PositiveID Corporation Comments on Digital Angel Corporation’s Response to Acquisition Proposal
September 17, 2010
PositiveID Urges Digital Angel's Board of Directors to Call a Special Meeting to Consider the Offer DELRAY BEACH, Fla. - PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID) commented today on Digital Angel Corporation's ("DIGA") (Nasdaq:DIGA) response to the Company's proposal to acquire all of the outstanding common stock of DIGA through a merger transaction. Prior [...]
New Contract Services for Nanoparticles and Surface Dissolution
September 16, 2010
Paraytec Ltd (York, UK) announce the launch of a new contract services business. Dr Mebs Surve, Business Development Director for Paraytec explained ‘Our new contract analysis and contract research business is based on Paraytec’s ground breaking technologies for sizing biopharmaceuticals and nanoparticles and also for surface dissolution imaging. These services are designed for customers who [...]
PositiveID Corporation Presents Offer to Acquire Digital Angel Corporation at 60 Percent Premium
September 16, 2010
Complementary Technologies Would Create New Revenue Opportunities and Leader in Unique Medical and Veterinary Products Including Rapid Medical Testing for Humans, Animals and Food Safety Applications Merger is Expected to be Accretive to PositiveID Stockholders With $35-$40 Million in Combined Revenue DELRAY BEACH, Fla. - PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID) announced today that [...]
Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate
September 16, 2010
Evaluating iCell Cardiomyocytes on the xCELLigence System Madison, Wisc. - Cellular Dynamics International (CDI) announced today their partnership with ACEA Biosciences to bring early and accurate prediction of potential cardiotoxic side effects to the drug discovery process. The partnership combines CDI’s induced pluripotent stem cell (iPSC)-derived heart cells, iCell™ Cardiomyocytes, with the xCELLigence™ RTCA System. [...]

